- Home
- TRST vs STOK Comparison
TRST vs STOK Comparison
Compare TRST & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRST
- STOK
- Stock Information
- Founded
- TRST 1902
- STOK 2014
- Country
- TRST United States
- STOK United States
- Employees
- TRST N/A
- STOK N/A
- Industry
- TRST Major Banks
- STOK Biotechnology: Pharmaceutical Preparations
- Sector
- TRST Finance
- STOK Health Care
- Exchange
- TRST Nasdaq
- STOK Nasdaq
- Market Cap
- TRST 627.3M
- STOK 721.4M
- IPO Year
- TRST N/A
- STOK 2019
- Fundamental
- Price
- TRST $36.77
- STOK $11.27
- Analyst Decision
- TRST
- STOK Strong Buy
- Analyst Count
- TRST 0
- STOK 7
- Target Price
- TRST N/A
- STOK $21.40
- AVG Volume (30 Days)
- TRST 78.3K
- STOK 460.7K
- Earning Date
- TRST 10-21-2024
- STOK 11-05-2024
- Dividend Yield
- TRST 3.90%
- STOK N/A
- EPS Growth
- TRST N/A
- STOK N/A
- EPS
- TRST 2.48
- STOK N/A
- Revenue
- TRST $168,593,000.00
- STOK $16,742,999.00
- Revenue This Year
- TRST N/A
- STOK $91.67
- Revenue Next Year
- TRST $11.69
- STOK $5.45
- P/E Ratio
- TRST $14.63
- STOK N/A
- Revenue Growth
- TRST N/A
- STOK 81.08
- 52 Week Low
- TRST $25.83
- STOK $3.77
- 52 Week High
- TRST $37.84
- STOK $17.58
- Technical
- Relative Strength Index (RSI)
- TRST 62.66
- STOK 33.56
- Support Level
- TRST $35.79
- STOK $11.08
- Resistance Level
- TRST $37.74
- STOK $14.72
- Average True Range (ATR)
- TRST 1.01
- STOK 0.75
- MACD
- TRST 0.05
- STOK -0.23
- Stochastic Oscillator
- TRST 81.03
- STOK 5.22
About TRST TrustCo Bank Corp NY
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The Company based on only one business segment, that of community banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey and Vermont.
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.